China Biologic Products Holdings, Inc. (NasdaqGS:CBPO) will look for acquisitions. Bing Li, Chief Executive Officer and Director said, "As part of our cost strategy, we will continue to assess suitable acquisition targets that will better position China Biologic for the long-term growth."